Skip to Main content Skip to Navigation
New interface
Journal articles

Arylsulfone-based HIV-1 non-nucleoside reverse transcriptase inhibitors.

Abstract : HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) represent one of the most significant classes of drugs for the treatment of AIDS/HIV infection. Over the past two decades several potent arylsulfone-based HIV-1 NNRTIs and related analogs have been developed. This review provides an essential overview of the structure-activity relationships of the arylsulfone-based HIV-1 NNRTIs. Furthermore, structural information useful for the design and development of new sulfur containing NNRTIs with enhanced antiretroviral activity against HIV-1 wild type and clinically relevant drug resistant HIV-1 mutant strains will be discussed.
Document type :
Journal articles
Complete list of metadata
Contributor : Istituto Pasteur Fondazione Cenci Bolognetti Connect in order to contact the contributor
Submitted on : Tuesday, August 5, 2014 - 1:42:58 PM
Last modification on : Friday, November 25, 2022 - 7:04:09 PM
Long-term archiving on: : Tuesday, April 11, 2017 - 6:56:22 PM


 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document




Valeria Famiglini, Antonio Coluccia, Andrea Brancale, Sveva Pelliccia, Giuseppe La Regina, et al.. Arylsulfone-based HIV-1 non-nucleoside reverse transcriptase inhibitors.. Future Medicinal Chemistry, 2013, 5 (18), pp.2141-56. ⟨10.4155/fmc.13.174⟩. ⟨pasteur-01054201⟩



Record views